AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. VIR
  4. [144] Vir Biotechnology, Inc. SEC Filing

[144] Vir Biotechnology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source:

Stock VIR logo
Vir Biotechnology, Inc.

NASDAQ:VIR

VIR Rankings

#3073 Ranked by Market Cap
N/A Ranked by Dividends

VIR Latest News

Aug 6, 2025
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Aug 6, 2025
Vir Biotechnology Successfully Initiates all Trials in ECLIPSE Registrational Program for Chronic Hepatitis Delta
Jul 31, 2025
Vir Biotechnology Initiates Second Pivotal Trial in Its Global ECLIPSE Registrational Program for Chronic Hepatitis Delta
Jul 24, 2025
Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN� Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors
Jul 22, 2025
Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2025 Financial Results on August 6, 2025

VIR Latest SEC Filings

Aug 6, 2025
[10-Q] Vir Biotechnology, Inc. Quarterly Earnings Report
Aug 4, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity
Jul 24, 2025
[8-K] Vir Biotechnology, Inc. Reports Material Event
Jul 17, 2025
[Form 4] Vir Biotechnology, Inc. Insider Trading Activity
Jul 17, 2025
[144] Vir Biotechnology, Inc. SEC Filing

VIR Stock Data

605.68M
105.26M
10.51%
82.3%
8.02%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN FRANCISCO